#biohacking
BPC-157, the ‘Wolverine’ Peptide: Documented Use Is Rising, but Human Safety Data Is Thin
Written by
Newly confirmed BPC-157 users per quarter rose 33-fold from 2020 to 2026 in one U.S. network’s clinical notes, according to a preprint that has not been peer reviewed. A 2025 review found only three very small human pilot studies. Here’s what the sources show, and what they can’t. Read more…
BPC-157 and TB-500: What FDA Reviewers Found
Written by
FDA staff reviewed seven popular peptides in July 2026 and found little human evidence on whether BPC-157 or TB-500 work or are safe. An advisory committee voted 8-6 in favor of adding BPC-157, as reported by ABC News; the vote is advice only. Read more…
Can Productivity Culture Fuel Burnout? One Therapist Thinks So
Written by
Psychotherapist Phil Lane argues that today’s culture of optimization can leave people more worn out instead of less. It is one clinician’s view, not a study. Read more…
The Whole-Stack Trap: Why We Start With Fewer Protocols
Written by
Every protocol you add to your life has a compliance tax. The tax has four components: mental overhead (remembering to do it), scheduling friction (finding t… Read more…
